59 related articles for article (PubMed ID: 17078922)
1. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
Roda Rani KP; Pelluru D; Kondapi AK
Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922
[TBL] [Abstract][Full Text] [Related]
2. Identification of the potential regions of Epap-1 that interacts with V3 loop of HIV-1 gp120.
Bhaskar C; Reddy PS; Chandra KS; Sabde S; Mitra D; Kondapi AK
Biochim Biophys Acta; 2013 Apr; 1834(4):780-90. PubMed ID: 23360764
[TBL] [Abstract][Full Text] [Related]
3. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.
Kadow J; Wang HG; Lin PF
Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683
[TBL] [Abstract][Full Text] [Related]
5. Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
Repits J; Sterjovski J; Badia-Martinez D; Mild M; Gray L; Churchill MJ; Purcell DF; Karlsson A; Albert J; Fenyö EM; Achour A; Gorry PR; Jansson M
Virology; 2008 Sep; 379(1):125-34. PubMed ID: 18672260
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV entry by carbohydrate-binding proteins.
Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
[TBL] [Abstract][Full Text] [Related]
8. Anti-HIV activity of a glycoprotein from first trimester placental tissue.
Kondapi AK; Hafiz MA; Sivaram T
Antiviral Res; 2002 Apr; 54(1):47-57. PubMed ID: 11888657
[TBL] [Abstract][Full Text] [Related]
9. [A non-infectious and quantitative cell-based bioassay for screening HIV entry inhibitors targeting HIV envelope proteins].
Li MM; Xia CL; Mao QC; Jiang SB; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):941-4. PubMed ID: 20501362
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells.
Du SX; Xu L; Viswanathan S; Whalen RG
Protein Expr Purif; 2008 Jun; 59(2):223-31. PubMed ID: 18406166
[TBL] [Abstract][Full Text] [Related]
11. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
[TBL] [Abstract][Full Text] [Related]
12. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.
Pfeiffer T; Pisch T; Devitt G; Holtkotte D; Bosch V
FEBS Lett; 2006 Jun; 580(15):3775-8. PubMed ID: 16777098
[TBL] [Abstract][Full Text] [Related]
13. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.
Martinelli E; Cicala C; Van Ryk D; Goode DJ; Macleod K; Arthos J; Fauci AS
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3396-401. PubMed ID: 17360657
[TBL] [Abstract][Full Text] [Related]
15. Role of the HIV gp120 conserved domain 5 in processing and viral entry.
Sen J; Jacobs A; Caffrey M
Biochemistry; 2008 Jul; 47(30):7788-95. PubMed ID: 18597484
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
[TBL] [Abstract][Full Text] [Related]
17. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato.
Kim TG; Gruber A; Langridge WH
Protein Expr Purif; 2004 Sep; 37(1):196-202. PubMed ID: 15294298
[TBL] [Abstract][Full Text] [Related]
19. Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120.
Ogert RA; Wojcik L; Buontempo C; Ba L; Buontempo P; Ralston R; Strizki J; Howe JA
Virology; 2008 Apr; 373(2):387-99. PubMed ID: 18190945
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
